New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

The Society of Thoracic Surgeons (STS) today announced the launch of its latest surgical risk calculator designed for patients undergoing ascending aorta and aortic root surgery, with or without ...